Cargando…
COVID-19 and Dementia
The World Health Organization has declared the COVID-19 outbreak a pandemic. The causative agent for COVID-19 is an RNA virus of the Coronaviridae family. In addition to the respiratory and other complications, a significant proportion of COVID-19 patients show neurological manifestations. Dementia...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558990/ https://www.ncbi.nlm.nih.gov/pubmed/34733061 http://dx.doi.org/10.1177/09727531211009420 |
_version_ | 1784592681981181952 |
---|---|
author | Sharma, Shiv K. |
author_facet | Sharma, Shiv K. |
author_sort | Sharma, Shiv K. |
collection | PubMed |
description | The World Health Organization has declared the COVID-19 outbreak a pandemic. The causative agent for COVID-19 is an RNA virus of the Coronaviridae family. In addition to the respiratory and other complications, a significant proportion of COVID-19 patients show neurological manifestations. Dementia is a neurocognitive disorder, the prevalence of which is projected to increase in the coming decades. This review provides an overview of the effects of COVID-19 on dementia patients. |
format | Online Article Text |
id | pubmed-8558990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-85589902021-11-02 COVID-19 and Dementia Sharma, Shiv K. Ann Neurosci Review Articles The World Health Organization has declared the COVID-19 outbreak a pandemic. The causative agent for COVID-19 is an RNA virus of the Coronaviridae family. In addition to the respiratory and other complications, a significant proportion of COVID-19 patients show neurological manifestations. Dementia is a neurocognitive disorder, the prevalence of which is projected to increase in the coming decades. This review provides an overview of the effects of COVID-19 on dementia patients. SAGE Publications 2021-06-03 2021-01 /pmc/articles/PMC8558990/ /pubmed/34733061 http://dx.doi.org/10.1177/09727531211009420 Text en © 2021 Indian Academy of Neurosciences (IAN) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Articles Sharma, Shiv K. COVID-19 and Dementia |
title | COVID-19 and Dementia |
title_full | COVID-19 and Dementia |
title_fullStr | COVID-19 and Dementia |
title_full_unstemmed | COVID-19 and Dementia |
title_short | COVID-19 and Dementia |
title_sort | covid-19 and dementia |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558990/ https://www.ncbi.nlm.nih.gov/pubmed/34733061 http://dx.doi.org/10.1177/09727531211009420 |
work_keys_str_mv | AT sharmashivk covid19anddementia |